You are here: Industry Insights > teva

News List

Teva, Modag to develop drug candidates for neurodegenerative disease Pharmaceutical-Business-Review
October 29, 2021
Teva Pharmaceutical has partnered with Modag for the development and licensing of the latter’s drug candidates, anle138b and sery433, for neurodegenerative disease.
Teva Recalls Lot of Contaminated Topotecan 4 mg/4 mL Injection americanpharmaceuticalreview
July 05, 2021
Teva Pharmaceuticals has initiated a voluntary recall of lot 31328962B of Topotecan Injection 4 mg/4 mL (1 mg/mL), to the retail/institutional level in the United States.
Global API market to value $300 billion by 2030 europeanpharmaceuticalreview
June 25, 2021
Researchers anticipate the growth of the aging population and rising investment in biologic drugs to promote the expansion of the global active pharmaceutical ingredient (API) market.
Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia prnasia
April 01, 2021
Frontier Pharma and Baystone Group today announced the completion of its acquisition of Zdravlje A.D from Teva Pharmaceuticals. Zdravlje currently supplies high quality pharmaceuticals to more than 35 international markets including those in ...
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma expresspharma
March 10, 2021
Indoco Remedies announces the launch of Brinzolamide Ophthalmic Suspension 1% in the US, the first generic version of AZOPT by Teva Pharmaceuticals. The product is developed and manufactured by Indoco Remedies for TEVA at its facility in Goa.
Connected drug delivery devices market to grow to $4bn by 2028 europeanpharmaceuticalreview
March 04, 2021
A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices.
Teva launches generic vaginal ring in US expresspharma
January 18, 2021
Etonogestrel and ethinyl estradiol vaginal ring, indicated for use by females of reproductive age to prevent pregnancy, contains a combination of a progestin and estrogen, two kinds of female hormones.
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia pharmaceutical-business-review
January 13, 2021
Teva Pharmaceuticals Industries and MedinCell announced positive results for study TV46000-CNS-30072 (the RISE study – The Risperidone Subcutaneous Extended-Release Study), a Phase 3 clinical trial designed to evaluate the efficacy of TV-46000/mdc-IRM ...
EC fines Teva and Cephalon €60.5 million over pay-for-delay deal europeanpharmaceuticalreview
November 30, 2020
The European Commission has fined Teva and Cephalon €60.5 million for a pay-for-delay deal over Cephalon’s modafinil and Teva’s generic.
Teva Charged in Ongoing Criminal Antitrust Investigation americanpharmaceuticalreview
September 07, 2020
Teva Pharmaceuticals USA has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice announced.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page